Archive for April 2021

We wanted to advance new ways of using technology to help people to feel connected and cared for and supported. We primarily focus on partnering with particular health plans, although we work with any healthcare organization who has a motivation to help people kind of in between those encounters,” Sattelmair said. Read More

Joya Misra, a UMass Amherst sociologist who studies how public policies influence inequality, answered four questions about paid leave in the U.S. Read More

While some in the life sciences industry create drugs and devices to tackle the Covid-19 pandemic, their colleagues are busy as ever raising money, testing new drugs, expanding facilities and more. Here’s The Petri Dish, a roundup of news that may get overlooked amid the influx of Greater Boston life sciences and health care happenings.…

“Having a physical presence in Memphis will also allow us to better interact with our tenants.” Read More

Since late January or early February this year, Wasabi CEO David Friend said he got half a dozen calls from SPACs. "We’re sort of a high flyer, and they’re looking for these kinds of deals," he said. Read More

The Buffalo-based bank will soon have a much bigger Boston presence, thanks to its pending $7.6 billion acquisition of People’s United. CEO René Jones knows Boston well, having grown up in Ayer and started his career here. Jones spoke with the Business Journal about the bank’s place in the local market. Read More

Among the many takeaways for Massachusetts from the latest once-in-a-decade Census data released this week is that one of the biggest factors helping the state hold onto political power at the federal level is immigration. Read More

The incoming board chair of the Mass. Society of CPAs wants to expand resources to smaller CPA firms, helping them with HR, training, retention and recruiting from a more diverse talent pool. He is challenging his fellow CPAs to broaden their recruiting to non-Ivy League schools: The students at community colleges aren’t there because they’re…

Cambridge biotech Moderna Inc. is doubling its manufacturing capacity to 3 billion doses of its Covid-19 vaccine in 2022, fueled by new local and international partnerships and an additional $236 million from the U.S. Biomedical Advanced Research and Development Authority. Read More